Perioperative handling of patients on antiplatelet therapy with need for surgery

被引:0
|
作者
Matteo Nicola Dario Di Minno
Domenico Prisco
Anna Lilia Ruocco
Pasquale Mastronardi
Salvatore Massa
Giovanni Di Minno
机构
[1] Federico II University,Department of Experimental and Clinical Medicine
[2] University of Florence,Department of Medical and Surgical Critical Care
[3] “Federico II” University,Department of Anesthesiology
[4] “Federico II” University,Department of Surgical Sciences
来源
关键词
Perioperative; Antiplatelet; Surgery;
D O I
暂无
中图分类号
学科分类号
摘要
The widespread use of metal stents and drug-eluting stents has shown the extent to which patients with unstable coronary perfusion depend on antiplatelet drugs, and how their risk of late thrombosis depends on the long-term use of agents such as clopidogrel. It has also been shown that the risk of surgical bleeding, if antiplatelet drugs are continued, is lower than that of coronary thrombosis if they are withdrawn. Thus, except for low-risk settings, the practice of withdrawing antiplatelet drugs 5–10 days prior to surgical procedures should be changed. The following suggestions are meant to provide a guideline in this respect. Most of the current surgical procedures may be performed while on low-dose aspirin treatment. Except when bleeding may occur in closed spaces (e.g. intracranial surgery, spinal surgery in the medullary canal, surgery of the posterior chamber of the eye) or where excessive blood loss is expected, where only clopidogrel should be discontinued; in all other cases the surgical procedures should be carried out in the presence of dual antiplatelet agents (if prescribed). Aspirin may be discontinued only in subjects at low risk of thrombosis, and at high risk of intraoperative bleeding. Operations associated with an expected excessive blood loss should be postponed unless vital. When prescribed for acute coronary syndrome or during stent re-endothelialization, clopidogrel should not be discontinued before a noncardiac procedure. For elective procedures, surgery should be postponed until the end of the indication for clopidogrel. After the operation, clopidogrel should be resumed within the 12–24 h. Cardiac procedures should be postponed for at least 4 days after clopidogrel withdrawal. The thrombotic risk of preoperative withdrawal of antiplatelet drugs overwhelms the benefit of regional or neuraxial blockade. Antiplatelet treatment replacement by heparin or low-molecular weight heparin does not provide protection against the risk of coronary artery or stent thrombosis. Haemostasis requires that at least 20% of circulating platelets have a normal function. As the effects of antiplatelet agents are not reversible by other drugs, fresh platelets are the only manner to rapidly restore normal haemostasis. Aprotinin decreases postoperative bleeding and transfusion rates in patients undergoing CABG and on clopidogrel during the days preceding surgery.
引用
收藏
页码:279 / 288
页数:9
相关论文
共 50 条
  • [1] Perioperative handling of patients on antiplatelet therapy with need for surgery
    Di Minno, Matteo Nicola Dario
    Prisco, Domenico
    Ruocco, Anna Lilia
    Mastronardi, Pasquale
    Massa, Salvatore
    Di Minno, Giovanni
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2009, 4 (04) : 279 - 288
  • [2] Perioperative Management of Antiplatelet Therapy in Patients with Coronary Stent Who Need Thoracic Surgery
    Hirayama, Shunki
    Matsunaga, Takeshi
    Takamochi, Kazuya
    Oh, Shiaki
    Suzuki, Kenji
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1398 - S1398
  • [3] Perioperative management of antiplatelet therapy in noncardiac surgery
    Filipescu, Daniela C.
    Stefan, Mihai G.
    Valeanu, Liana
    Popescu, Wanda M.
    [J]. CURRENT OPINION IN ANESTHESIOLOGY, 2020, 33 (03) : 454 - 462
  • [4] Perioperative handling of antiplatelet therapy: watching the two sides of the coin
    Paolo Gresele
    [J]. Internal and Emergency Medicine, 2009, 4 : 275 - 276
  • [5] Perioperative handling of antiplatelet therapy: watching the two sides of the coin
    Gresele, Paolo
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2009, 4 (04) : 275 - 276
  • [6] Perioperative management of oral antiplatelet therapy in patients with coronary stents undergoing surgery
    Rossini, R.
    Musumeci, G.
    Capodanno, D.
    Lettieri, C.
    Limbruno, U.
    Valsecchi, O.
    Russo, N.
    Guagliumi, G.
    Angiolillo, D.
    Gavazzi, A.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 : 880 - 881
  • [7] Perioperative antiplatelet therapy and cardiovascular outcomes in patients undergoing joint and spine surgery
    Smilowitz, Nathaniel R.
    Oberweis, Brandon S.
    Nukala, Swetha
    Rosenberg, Andrew
    Stuchin, Steven
    Iorio, Richard
    Errico, Thomas
    Radford, Martha J.
    Berger, Jeffrey S.
    [J]. JOURNAL OF CLINICAL ANESTHESIA, 2016, 35 : 163 - 169
  • [8] Maintenance of perioperative antiplatelet and anticoagulant therapy for vitreoretinal surgery
    Ryan, Andrea
    Saad, Tahira
    Kirwan, Caitriona
    Keegan, David J.
    Acheson, Robert W.
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 41 (04): : 387 - 395
  • [9] There will be blood - perioperative anticoagulation and antiplatelet therapy in prostate surgery
    Lee, J.
    Wang, N.
    [J]. BJU INTERNATIONAL, 2018, 121 : 42 - 42
  • [10] Perioperative Management of Antiplatelet Therapy in Patients With a Coronary Stent Who Need Noncardiac Surgery A Systematic Review of Clinical Practice Guidelines
    Darvish-Kazem, Saeed
    Gandhi, Mandark
    Marcucci, Maura
    Douketis, James D.
    [J]. CHEST, 2013, 144 (06) : 1848 - 1856